Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Pulmonology

Protecting Your Breathing and Nutrition in PMA

At a Glance

Progressive muscular atrophy can gradually weaken breathing and swallowing muscles, so regular monitoring and early planning for non-invasive ventilation, cough assistance, or a feeding tube can help protect breathing, nutrition, and independence; emergency symptoms require immediate care.

While Progressive Muscular Atrophy (PMA) often moves more slowly than classic ALS, the most critical risks involve the muscles that help you breathe and swallow [1]. Because these changes can happen gradually, your care team uses approximate clinician-guided prompts to decide when to start extra support. The goal is to act proactively, ensuring you stay well-nourished and breathe comfortably before an emergency occurs. Importantly, do not wait for a specific cutoff before reporting symptoms [2][3].

Monitoring Your Breathing

Your team will test your lung function approximately every three months [4]. They look at several key numbers:

  • Forced Vital Capacity (FVC): The total amount of air you can exhale after a deep breath. A historical reference point for starting support is when your FVC drops below 50% of its predicted value, though some teams start earlier if you have symptoms [5][6].
  • MIP and SNIP: These tests measure the strength of your “inhaling” muscles. A Maximal Inspiratory Pressure (MIP) of less than 60 cm H₂O often signals that the diaphragm is weakening [6][7].
  • Peak Cough Flow (PCF): This measures how well you can clear your airway. If your cough is too weak to clear mucus, your doctor may prescribe a cough-assist machine to prevent lung infections [8].
    These are historical or commonly used reference points, not stand-alone rules.

Non-Invasive Ventilation (NIV)

Non-Invasive Ventilation (NIV)—usually a machine like a BiPAP—uses a mask to help push air into your lungs. Research shows that using NIV can improve quality of life and significantly extend survival, a benefit well established in selected ALS populations and often qualified for PMA [9][10].

You may need NIV if you experience orthopnea (difficulty breathing while lying flat) or if you wake up with morning headaches, which can be a sign that you aren’t breathing deeply enough during sleep (nocturnal hypoventilation). Your doctor may use overnight oximetry or carbon-dioxide monitoring to detect this [11][12].

Managing Nutrition and Swallowing

As swallowing becomes more difficult (dysphagia), it becomes harder to get enough calories. Your team will look for these specific triggers to discuss a gastrostomy (PEG) tube—a small feeding tube placed in the stomach:

  • Weight Loss: Losing more than 10% of your body weight is a major indicator that your body needs more support, though any unintentional downward trend should be addressed [3].
  • Meal Duration: If it takes you longer than 45 minutes to finish a meal due to chewing or swallowing struggles [3].
  • Decline in Lung Function: Doctors prefer to place a PEG tube while your FVC is still above 50%. While it can be done safely later, doing it earlier reduces the risk of respiratory complications during the procedure [13][14].

A PEG supports nutrition and hydration but does not prevent aspiration of saliva or reflux, and it does not eliminate the need for a formal swallowing assessment.

Warning Signs and Urgent Actions

Some symptoms require immediate medical attention. If you experience any of the following, refer to this guide:

Symptom What it May Mean Action Required
Acute Choking with Inability to Breathe or Speak Airway obstruction. Call emergency services immediately.
Severe Shortness of Breath or Blue Lips Acute respiratory failure; your muscles can no longer keep up with your body’s demand for oxygen [15][16]. Call emergency services immediately.
Sudden Fever & Worsening Cough after Choking Possible aspiration event or pneumonia; food or liquid may have entered your lungs [9]. Seek urgent medical assessment.
New Confusion or Extreme Morning Sleepiness A sign of “CO₂ retention,” where your body is not exhaling enough carbon dioxide [17]. Contact your pulmonologist or go to urgent care.

Having these supports in place—like an NIV machine or a feeding tube—is not about giving up; it is about providing your body with the tools it needs to maintain your energy and independence for as long as possible [2][18].

Common questions in this guide

When should a person with PMA ask about non-invasive ventilation?
Ask your care team about non-invasive ventilation if you have trouble breathing when lying flat, morning headaches, unusual daytime sleepiness, or tests suggesting shallow breathing during sleep. Overnight oxygen or carbon-dioxide monitoring, along with symptoms and lung-function results, can help determine whether this support is appropriate.
What do FVC, MIP, SNIP, and peak cough flow show in PMA?
FVC estimates how much air you can exhale, MIP and SNIP assess the strength of the muscles used to inhale, and peak cough flow shows how well you can clear mucus. Values such as FVC below 50% of predicted or MIP below 60 cm H₂O are historical reference points, not stand-alone rules; symptoms and changes over time also matter.
When should a PEG feeding tube be discussed in PMA?
Discuss a PEG when swallowing difficulty causes unintentional weight loss, meals take longer than about 45 minutes, or you cannot maintain enough calories and hydration. Care teams often prefer placement while FVC remains above 50% of predicted, but timing is individualized and any downward weight trend should be reported early.
Will a PEG tube prevent aspiration in PMA?
No. A PEG can provide nutrition and hydration, but it does not prevent aspiration of saliva or reflux and does not replace a formal swallowing assessment.
How can a cough-assist machine help someone with PMA?
A cough-assist machine helps move air to produce a stronger cough when the breathing muscles are weak. It may help clear mucus and reduce the risk of mucus-related lung infections, but your clinician should determine whether and how to use it.
Which PMA breathing or swallowing symptoms are emergencies?
Call emergency services immediately for choking that prevents breathing or speaking, severe shortness of breath, or blue lips. New confusion, extreme morning sleepiness, or fever with a worsening cough after choking needs urgent medical assessment because it may signal carbon-dioxide retention or aspiration-related illness.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Progressive muscular atrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are my current seated and supine FVC, MIP, and SNIP scores, and how do they compare to my previous tests?
  2. 2.Given my symptoms and breathing scores, is it appropriate to order overnight oximetry or discuss starting non-invasive ventilation (NIV)?
  3. 3.Based on my swallowing assessment and weight trends, should we discuss the timeline and shared decision-making for placing a gastrostomy (PEG) tube?
  4. 4.Can we review a clear plan for what to do during an acute choking episode or if I experience sudden, severe shortness of breath?
  5. 5.Are there specific techniques or devices, like a cough-assist machine, that can help me clear mucus more effectively?

References

References (18)
  1. 1

    MND Phenotypes Differentiation: The Role of Multimodal Characterization at the Time of Diagnosis.

    Meo G, Ferraro PM, Cillerai M, et al.

    Life (Basel, Switzerland) 2022; (12(10)) doi:10.3390/life12101506.

    PMID: 36294940
  2. 2

    Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis/motor neuron disease: a systematic review.

    Baxter SK, Johnson M, Clowes M, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(7-8)):461-472 doi:10.1080/21678421.2019.1627372.

    PMID: 31204525
  3. 3

    Predictive factors for gastrostomy at time of diagnosis and impact on survival in patients with amyotrophic lateral sclerosis.

    Vergonjeanne M, Fayemendy P, Marin B, et al.

    Clinical nutrition (Edinburgh, Scotland) 2020; (39(10)):3112-3118 doi:10.1016/j.clnu.2020.01.018.

    PMID: 32063408
  4. 4

    Evaluation of remote pulmonary function testing in motor neuron disease.

    Geronimo A, Simmons Z

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(5-6)):348-355 doi:10.1080/21678421.2019.1587633.

    PMID: 30957547
  5. 5

    Initiation of noninvasive ventilation in patients with amyotrophic lateral sclerosis.

    Jimenez JV, Tang MJ, Wilson MW, et al.

    Muscle & nerve 2024; (70(5)):1099-1103 doi:10.1002/mus.28250.

    PMID: 39243146
  6. 6

    Comparative Performance of Different Respiratory Test Parameters for Detection of Early Respiratory Insufficiency in Patients With ALS.

    Kelly CR, Parra-Cantu C, Thapa P, et al.

    Neurology 2022; (99(7)):e743-e750 doi:10.1212/WNL.0000000000200758.

    PMID: 35584920
  7. 7

    Assessing Inspiratory Muscle Strength for Early Detection of Respiratory Failure in Motor Neuron Disease: Should We Use MIP, SNIP, or Both?

    Janssens JP, Adler D, Iancu Ferfoglia R, et al.

    Respiration; international review of thoracic diseases 2019; (98(2)):114-124 doi:10.1159/000498972.

    PMID: 31018212
  8. 8

    Rapidly and slowly progressive neuromuscular disease: differences in pulmonary function, respiratory tract infections and response to lung volume recruitment therapy (LVR).

    Sheers NL, Berlowitz DJ, Dirago RK, et al.

    BMJ open respiratory research 2022; (9(1)) doi:10.1136/bmjresp-2022-001241.

    PMID: 36600411
  9. 9

    Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients.

    Burkhardt C, Neuwirth C, Sommacal A, et al.

    PloS one 2017; (12(5)):e0177555 doi:10.1371/journal.pone.0177555.

    PMID: 28542233
  10. 10

    Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.

    Radunovic A, Annane D, Rafiq MK, et al.

    The Cochrane database of systematic reviews 2017; (10()):CD004427 doi:10.1002/14651858.CD004427.pub4.

    PMID: 28982219
  11. 11

    Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation?

    Prell T, Ringer TM, Wullenkord K, et al.

    Journal of neurology, neurosurgery, and psychiatry 2016; (87(9)):1022-6 doi:10.1136/jnnp-2015-312185.

    PMID: 27010615
  12. 12

    Early assessment in bulbar-onset amyotrophic lateral sclerosis detects similar rates of nocturnal desaturation and orthopnoea compared to non-bulbar-onset disease.

    Luu S, McGuiness OA, Menadue C, et al.

    Sleep & breathing = Schlaf & Atmung 2025; (30(1)):3.

    PMID: 41348294
  13. 13

    Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis.

    Russ KB, Phillips MC, Wilcox CM, Peter S

    The American journal of the medical sciences 2015; (350(2)):95-7 doi:10.1097/MAJ.0000000000000517.

    PMID: 26135224
  14. 14

    Safety of Gastrostomy Tube Placement in Patients with Advanced Amyotrophic Lateral Sclerosis With Noninvasive Ventilation.

    Kim EY, Kang SW, Suh MR, et al.

    JPEN. Journal of parenteral and enteral nutrition 2021; (45(6)):1338-1346 doi:10.1002/jpen.2018.

    PMID: 32914883
  15. 15

    Emergencies in Amyotrophic Lateral Sclerosis.

    Uysal SP, Dudley KA, Sullivan S, et al.

    Muscle & nerve 2026; doi:10.1002/mus.70398.

    PMID: 42702895
  16. 16

    When Hypercapnia Misleads: A Case of Respiratory-Onset Motor Neuron Disease.

    Kordi Y, Ismail M, Estabrook E

    Cureus 2026; (18(10)):e117375 doi:10.7759/cureus.117375.

    PMID: 42831156
  17. 17

    Mortality and Complications of Percutaneous Gastrostomy in Amyotrophic Lateral Sclerosis Patients.

    Dallaire JS, Bachand MP, Shaul J, Lareau-Trudel E

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2026; 1-8 doi:10.1017/cjn.2025.10510.

    PMID: 41492782
  18. 18

    An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials.

    van Eijk RPA, de Jongh AD, Nikolakopoulos S, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2021; (22(3-4)):300-307 doi:10.1080/21678421.2021.1879865.

    PMID: 33527843

This page is for informational purposes only and does not constitute medical advice. Discuss PMA breathing, swallowing, NIV, and PEG decisions with your healthcare team, and seek emergency help for severe breathing problems or choking.